000566 海南海药
已收盘 08-20 15:00:00
资讯
新帖
简况
海南海药（000566）8月19日主力资金净卖出1083.49万元
证券之星 · 08-20 09:04
海南海药（000566）8月19日主力资金净卖出1083.49万元
A股医药板块震荡反弹，海辰药业涨超15%，上海谊众、亚太药业、广生堂、浙江医药、海南海药、普利制药等跟涨。
美港电讯 · 08-16
A股医药板块震荡反弹，海辰药业涨超15%，上海谊众、亚太药业、广生堂、浙江医药、海南海药、普利制药等跟涨。
海南海药最新公告：氟非尼酮胶囊Ⅱ期临床试验期中分析结果显示达到主要研究终点
证券之星 · 08-15
海南海药最新公告：氟非尼酮胶囊Ⅱ期临床试验期中分析结果显示达到主要研究终点
海南海药(000566.SZ)：氟非尼酮胶囊Ⅱ期临床试验期中分析已经完成
智通财经 · 08-15
海南海药(000566.SZ)：氟非尼酮胶囊Ⅱ期临床试验期中分析已经完成
海南海药：公司年报披露的高管薪酬为税前金额
证券之星 · 08-13
海南海药：公司年报披露的高管薪酬为税前金额
海南海药最新公告：副董事长刘悉承辞职
证券之星 · 08-13
海南海药最新公告：副董事长刘悉承辞职
8月13日海南海药涨停分析：海南自由贸易港，海南概念，自贸区概念热股
证券之星 · 08-13
8月13日海南海药涨停分析：海南自由贸易港，海南概念，自贸区概念热股
海南海药最新公告：与PHARMATHEN S.A.签署权益许可和经销协议
证券之星 · 08-12
海南海药最新公告：与PHARMATHEN S.A.签署权益许可和经销协议
海南海药(000566.SZ)与希腊PHARMATHEN签署权益许可和经销协议 拓展神经精神领域产品
智通财经 · 08-12
海南海药(000566.SZ)与希腊PHARMATHEN签署权益许可和经销协议 拓展神经精神领域产品
海南海药：截止2024年7月31日，公司股东总户数46,678户
证券之星 · 08-02
海南海药：截止2024年7月31日，公司股东总户数46,678户
海南海药：公司目前暂无减肥药产品
证券之星 · 07-30
海南海药：公司目前暂无减肥药产品
海南海药最新公告：注射用头孢唑林钠通过仿制药质量和疗效一致性评价
证券之星 · 07-29
海南海药最新公告：注射用头孢唑林钠通过仿制药质量和疗效一致性评价
【海南海药(000566.SZ)：注射用头孢唑林钠通过仿制药一致性评价】智通财经APP讯，海南海药(000566.SZ)发布公告，公司全资子公司海口市制药厂有限公司(“海口市制药厂”)于近日获得国家药品监督管理局核准签发的化学药品“注射用头孢唑林钠”的《药品补充申请批准通知书》。
智通财经 · 07-29
【海南海药(000566.SZ)：注射用头孢唑林钠通过仿制药一致性评价】智通财经APP讯，海南海药(000566.SZ)发布公告，公司全资子公司海口市制药厂有限公司(“海口市制药厂”)于近日获得国家药品监督管理局核准签发的化学药品“注射用头孢唑林钠”的《药品补充申请批准通知书》。
海南海药(000566.SZ)：注射用头孢唑林钠通过仿制药一致性评价
智通财经 · 07-29
海南海药(000566.SZ)：注射用头孢唑林钠通过仿制药一致性评价
海南海药：截至2024年7月20日，公司股东户数为46,607
证券之星 · 07-23
海南海药：截至2024年7月20日，公司股东户数为46,607
海南海药：公司一直聚焦医药主业，加快两非两资处置、低效无效资产盘活
证券之星 · 07-18
海南海药：公司一直聚焦医药主业，加快两非两资处置、低效无效资产盘活
海南海药：目前公司暂无“普拿痛”系列药生产
证券之星 · 07-16
海南海药：目前公司暂无“普拿痛”系列药生产
海南海药：截至2024年7月10日，公司股东户数为46,993
证券之星 · 07-12
海南海药：截至2024年7月10日，公司股东户数为46,993
【海南海药(000566.SZ)发预亏 半年度净亏损1.3亿元-1.7亿元 同比由盈转亏】智通财经APP讯，海南海药(000566.
智通财经 · 07-10
【海南海药(000566.SZ)发预亏 半年度净亏损1.3亿元-1.7亿元 同比由盈转亏】智通财经APP讯，海南海药(000566.
海南海药(000566.SZ)发预亏 半年度净亏损1.3亿元-1.7亿元 同比由盈转亏
智通财经 · 07-10
海南海药(000566.SZ)发预亏 半年度净亏损1.3亿元-1.7亿元 同比由盈转亏
加载更多
公司概况
公司名称：
海南海药股份有限公司
所属行业：
医药制造业
上市日期：
1994-05-25
主营业务：
海南海药股份有限公司主营业务是药品及医疗器械研发、生产和销售。公司的主要产品是抗生素系列、胃肠道用药系列、抗肿瘤药系列、与制剂配套的原料药和中间体系列及其他产品。公司产品枫蓼肠胃康颗粒2023年市场占有率56%，国内排名第一，头孢唑肟钠2023年市场占有率10.6%，国内排名第二，头孢西丁钠2023年市场占有率15.9,%，国内排名第二。
发行价格：
5.80
{"stockData":{"symbol":"000566","market":"SZ","secType":"STK","nameCN":"海南海药","latestPrice":3.13,"timestamp":1724137401000,"preClose":3.2,"halted":0,"volume":10379270,"delay":0,"floatShares":1166000000,"shares":1297000000,"eps":-0.0979,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.07,"latestTime":"08-20 15:00:00","open":3.23,"high":3.23,"low":3.12,"amount":32755900,"amplitude":0.0344,"askPrice":3.14,"askSize":1272,"bidPrice":3.13,"bidSize":122,"shortable":0,"etf":0,"ttmEps":-0.0979,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1724203800000},"adr":0,"adjPreClose":3.2,"symbolType":"stock","openAndCloseTimeList":[[1724117400000,1724124600000],[1724130000000,1724137200000]],"highLimit":3.52,"lowLimit":2.88,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1297365126,"pbRate":2.03,"roa":"--","roe":"--","epsLYR":-0.0821,"committee":0.071383,"marketValue":4061000000,"floatMarketCap":3649000000,"peRate":-31.971398,"changeRate":-0.0219,"turnoverRate":0.0089,"status":1},"requestUrl":"/m/hq/s/000566","defaultTab":"news","newsList":[{"id":"2460097013","title":"海南海药（000566）8月19日主力资金净卖出1083.49万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460097013","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460097013?lang=zh_cn&edition=full","pubTime":"2024-08-20 09:04","pubTimestamp":1724115896,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年8月19日收盘，海南海药报收于3.2元，下跌3.32%，换手率1.54%，成交量17.9万手，成交额5779.73万元。近5日资金流向一览见下表：海南海药融资融券信息显示，融资方面，当日融资买入518.25万元，融资偿还686.37万元，融资净偿还168.12万元。海南海药主营业务：药品及医疗器械研发、生产和销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082000006504.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","000566","BK0060","BK0239","BK0146","BK0070"],"gpt_icon":0},{"id":"2459231238","title":"A股医药板块震荡反弹，海辰药业涨超15%，上海谊众、亚太药业、广生堂、浙江医药、海南海药、普利制药等跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2459231238","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459231238?lang=zh_cn&edition=full","pubTime":"2024-08-16 09:59","pubTimestamp":1723773542,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["399300","300584","BK0146","BK0239","300630","BK1574","688091","BK0070","BK0060","BK0188","BK1161","09939","159938","300436","002370","000566","BK0191","600216","BK0028","BK1515","BK0132","159982"],"gpt_icon":0},{"id":"2459658422","title":"海南海药最新公告：氟非尼酮胶囊Ⅱ期临床试验期中分析结果显示达到主要研究终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2459658422","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459658422?lang=zh_cn&edition=full","pubTime":"2024-08-15 21:11","pubTimestamp":1723727484,"startTime":"0","endTime":"0","summary":"海南海药公告，公司全资子公司海口市制药厂有限公司与中南大学联合申请的创新药氟非尼酮胶囊近日收到了独立数据监查委员会发送的DMC建议表。根据收到的DMC建议表结论:鉴于本研究已达到方案设定的主要研究终点，可终止II期临床试验的受试者入组，并考虑开展后续III期临床试验。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081500044225.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0146","BK0239","BK1576","03347","BK1141","000566","BK0188","BK0070","BK1583"],"gpt_icon":0},{"id":"2459423123","title":"海南海药(000566.SZ)：氟非尼酮胶囊Ⅱ期临床试验期中分析已经完成","url":"https://stock-news.laohu8.com/highlight/detail?id=2459423123","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459423123?lang=zh_cn&edition=full","pubTime":"2024-08-15 19:49","pubTimestamp":1723722557,"startTime":"0","endTime":"0","summary":"智通财经APP讯，海南海药 发布公告，公司全资子公司海口市制药厂有限公司与中南大学联合申请的创新药氟非尼酮胶囊近日收到了独立数据监查委员会发送的DMC建议表。根据试验计划，项目进行期中分析，目前期中分析已经完成，结果显示达到主要研究终点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1164903.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000566","BK0070","BK1576","BK1583","03347","BK0146","BK0188","BK0060","BK1141","BK0239"],"gpt_icon":0},{"id":"2459927000","title":"海南海药：公司年报披露的高管薪酬为税前金额","url":"https://stock-news.laohu8.com/highlight/detail?id=2459927000","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459927000?lang=zh_cn&edition=full","pubTime":"2024-08-13 18:04","pubTimestamp":1723543483,"startTime":"0","endTime":"0","summary":"海南海药董秘：您好，目前公司发展战略：一是大力发展化药板块，全面布局“6523”产品组合，打造原料药与制剂一体、仿制药与创新药结合的业务体系，成为中国有影响力的抗感染类药品制造商和中国最大的原料药和中间体制造商。海南海药董秘：您好，截至2024年8月10日，公司股东户数为46,784。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081300036161.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000566","BK0070","BK0146","BK0188","BK0060","BK0239"],"gpt_icon":0},{"id":"2459208869","title":"海南海药最新公告：副董事长刘悉承辞职","url":"https://stock-news.laohu8.com/highlight/detail?id=2459208869","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459208869?lang=zh_cn&edition=full","pubTime":"2024-08-13 18:00","pubTimestamp":1723543244,"startTime":"0","endTime":"0","summary":"海南海药公告，公司董事会于近日收到副董事长刘悉承的辞职报告，其由于个人原因申请辞去公司副董事长、董事及董事会相应专门委员会职务。辞职后，刘悉承将不再担任公司任何职务。根据相关规定，刘悉承的辞职不会使公司董事会人数低于法定最低人数，辞职不会影响公司董事会工作的正常运行，其辞职报告自送达公司董事会之日起生效。截至本公告披露日，刘悉承未直接持有公司股份。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081300036021.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0070","BK0239","BK0060","000566","BK0188"],"gpt_icon":0},{"id":"2459942723","title":"8月13日海南海药涨停分析：海南自由贸易港，海南概念，自贸区概念热股","url":"https://stock-news.laohu8.com/highlight/detail?id=2459942723","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459942723?lang=zh_cn&edition=full","pubTime":"2024-08-13 15:33","pubTimestamp":1723534422,"startTime":"0","endTime":"0","summary":"证券之星消息，海南海药8月13日涨停收盘，收盘价3.47元。该股于9点25分涨停，未打开涨停，截止收盘封单资金为5253.93万元，占其流通市值1.3%。近5日资金流向一览见下表：该股为海南自由贸易港，海南概念，自贸区概念热股，当日海南自由贸易港概念上涨0.97%，海南概念概念上涨0.82%，自贸区概念上涨0.64%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081300025810.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0239","BK0146","BK0060","000566","BK0188"],"gpt_icon":0},{"id":"2458600728","title":"海南海药最新公告：与PHARMATHEN S.A.签署权益许可和经销协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2458600728","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458600728?lang=zh_cn&edition=full","pubTime":"2024-08-12 20:49","pubTimestamp":1723466985,"startTime":"0","endTime":"0","summary":"海南海药公告，公司近日与PHARMATHEN S.A.签署了《权益许可和经销协议》，获得PHARMATHEN研发生产的用于精神分裂症治疗的药品棕榈酸帕利哌酮长效注射液在中国境内的独家排他商业化权益。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081200031029.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0146","BK0188","000566","BK0060","BK0070"],"gpt_icon":0},{"id":"2458600932","title":"海南海药(000566.SZ)与希腊PHARMATHEN签署权益许可和经销协议 拓展神经精神领域产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2458600932","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458600932?lang=zh_cn&edition=full","pubTime":"2024-08-12 20:47","pubTimestamp":1723466840,"startTime":"0","endTime":"0","summary":"智通财经APP讯，海南海药 发布公告，公司近日与PHARMATHEN S.A.签署了《权益许可和经销协议》，双方主要就PHARMATHEN研发生产的用于精神分裂症急性期和维持期的治疗药品Paliperidone Long Acting Injectable达成合作，获得该产品在中国境内独家排他的商业化权益。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1163185.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK0146","BK0188","000566","BK0060","BK0070"],"gpt_icon":0},{"id":"2456235564","title":"海南海药：截止2024年7月31日，公司股东总户数46,678户","url":"https://stock-news.laohu8.com/highlight/detail?id=2456235564","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456235564?lang=zh_cn&edition=full","pubTime":"2024-08-02 23:00","pubTimestamp":1722610835,"startTime":"0","endTime":"0","summary":"证券之星消息，海南海药(000566)08月02日在投资者关系平台上答复投资者关心的问题。投资者：请问截止2024年7月31日，公司股东人数多少？海南海药董秘：您好，截止2024年7月31日，公司股东总户数46,678户。谢谢！以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080200053366.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0146","BK0188","000566","BK0060","BK0070"],"gpt_icon":0},{"id":"2455879829","title":"海南海药：公司目前暂无减肥药产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2455879829","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455879829?lang=zh_cn&edition=full","pubTime":"2024-07-30 19:02","pubTimestamp":1722337363,"startTime":"0","endTime":"0","summary":"公司拥有男科中成药产品宝岛健阳片，主治补肾益精等。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024073000037082.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","000566","BK0060","BK0239","BK0146","BK0070"],"gpt_icon":0},{"id":"2455571651","title":"海南海药最新公告：注射用头孢唑林钠通过仿制药质量和疗效一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2455571651","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455571651?lang=zh_cn&edition=full","pubTime":"2024-07-29 19:51","pubTimestamp":1722253873,"startTime":"0","endTime":"0","summary":"海南海药公告，公司全资子公司海口市制药厂有限公司(以下简称“海口市制药厂”)于近日获得国家药品监督管理局核准签发的化学药品“注射用头孢唑林钠”的《药品补充申请批准通知书》。经审查，该品通过仿制药质量和疗效一致性评价。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072900030926.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0239","BK0070","000566","BK0060","BK0188"],"gpt_icon":0},{"id":"2455637690","title":"【海南海药(000566.SZ)：注射用头孢唑林钠通过仿制药一致性评价】智通财经APP讯，海南海药(000566.SZ)发布公告，公司全资子公司海口市制药厂有限公司(“海口市制药厂”)于近日获得国家药品监督管理局核准签发的化学药品“注射用头孢唑林钠”的《药品补充申请批准通知书》。","url":"https://stock-news.laohu8.com/highlight/detail?id=2455637690","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455637690?lang=zh_cn&edition=full","pubTime":"2024-07-29 18:10","pubTimestamp":1722247854,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK0146","BK0070","BK0239","BK0060","000566","BK0188"],"gpt_icon":0},{"id":"2455376786","title":"海南海药(000566.SZ)：注射用头孢唑林钠通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2455376786","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455376786?lang=zh_cn&edition=full","pubTime":"2024-07-29 18:10","pubTimestamp":1722247854,"startTime":"0","endTime":"0","summary":"智通财经APP讯，海南海药(000566.SZ)发布公告，公司全资子公司海口市制药厂有限公司(“海口市制药厂”)于近日获得国家药品监督管理局核准签发的化学药品“注射用头孢唑林钠”的《药品补充申请批准通知书》。经审查，本品通过仿制药质量和疗效一致性评价。根据国家相关政策，通过一致性评价的药品品种，质量和疗效等同原研产品，本次注射用头孢唑林钠通过一致性评价，将有利于提升该药品的市场竞争力，对公司业绩产生积极的影响。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1156922.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0070","BK0146","BK0060","BK0188","BK0239","000566"],"gpt_icon":0},{"id":"2453083190","title":"海南海药：截至2024年7月20日，公司股东户数为46,607","url":"https://stock-news.laohu8.com/highlight/detail?id=2453083190","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453083190?lang=zh_cn&edition=full","pubTime":"2024-07-23 17:05","pubTimestamp":1721725506,"startTime":"0","endTime":"0","summary":"证券之星消息，海南海药(000566)07月23日在投资者关系平台上答复投资者关心的问题。投资者：请问截止2024年7月20日，公司股东人数多少？海南海药董秘：您好，截至2024年7月20日，公司股东户数为46,607。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072300033401.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0070","000566","BK0188","BK0146","BK0060"],"gpt_icon":0},{"id":"2452105999","title":"海南海药：公司一直聚焦医药主业，加快两非两资处置、低效无效资产盘活","url":"https://stock-news.laohu8.com/highlight/detail?id=2452105999","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452105999?lang=zh_cn&edition=full","pubTime":"2024-07-18 18:04","pubTimestamp":1721297053,"startTime":"0","endTime":"0","summary":"海南海药董秘：您好，公司会尽全力通过法律途径为公司争取合法权益，公司将积极配合法院庭审并提供相关材料及证据，后续进展将以公告形式进行披露。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071800037692.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000566","159938","BK1515","BK0239","09939","BK1574","BK0188","BK0060","BK0146","BK0070","BK1161"],"gpt_icon":0},{"id":"2451965664","title":"海南海药：目前公司暂无“普拿痛”系列药生产","url":"https://stock-news.laohu8.com/highlight/detail?id=2451965664","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451965664?lang=zh_cn&edition=full","pubTime":"2024-07-16 17:04","pubTimestamp":1721120658,"startTime":"0","endTime":"0","summary":"海南海药董秘：海南海药正在通过“自研+授权引进”双轮驱动模式，完善产品矩阵，打开自身增长空间。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071600035154.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0239","BK0146","BK0070","BK0188","000566"],"gpt_icon":0},{"id":"2450585933","title":"海南海药：截至2024年7月10日，公司股东户数为46,993","url":"https://stock-news.laohu8.com/highlight/detail?id=2450585933","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450585933?lang=zh_cn&edition=full","pubTime":"2024-07-12 19:03","pubTimestamp":1720782197,"startTime":"0","endTime":"0","summary":"证券之星消息，海南海药07月12日在投资者关系平台上答复投资者关心的问题。投资者：请问截止2024年7月10日，公司股东人数多少？海南海药董秘：您好，截至2024年7月10日，公司股东户数为46,993。海南海药董秘：您好，公司于2024年6月份获得复方红豆杉胶囊药品批文，目前正加快销售渠道对接。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071200043351.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0070","BK0239","BK0146","BK0188","000566"],"gpt_icon":0},{"id":"2450897025","title":"【海南海药(000566.SZ)发预亏 半年度净亏损1.3亿元-1.7亿元 同比由盈转亏】智通财经APP讯，海南海药(000566.","url":"https://stock-news.laohu8.com/highlight/detail?id=2450897025","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450897025?lang=zh_cn&edition=full","pubTime":"2024-07-10 21:18","pubTimestamp":1720617500,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["000566","BK0239","BK0188","BK0146","BK0060","BK0070"],"gpt_icon":0},{"id":"2450002897","title":"海南海药(000566.SZ)发预亏 半年度净亏损1.3亿元-1.7亿元 同比由盈转亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2450002897","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450002897?lang=zh_cn&edition=full","pubTime":"2024-07-10 21:18","pubTimestamp":1720617500,"startTime":"0","endTime":"0","summary":"智通财经APP讯，海南海药(000566.SZ)披露2024年半年度业绩预告，该公司预计报告期归属于上市公司股东的净亏损1.3亿元-1.7亿元，同比由盈转亏。扣除非经常性损益后的净亏损8000万元-1.2亿元。业绩变动的主要原因：报告期信用减值损失预计金额约-0.27亿元，较上年同期0.70亿元增加约0.96亿元。主要系报告期根据最新诉讼进展情况，确认预计负债0.76亿元。报告期投资收益预计金额约-0.58亿元，较上年同期-0.12亿元减少约0.45亿元。主要系报告期债务重组损失0.39亿元所致。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1149018.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0060","BK0146","BK0239","000566","BK0188","BK0070"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"1994-05-25","address":"海南省海口市秀英区南海大道192号","stockEarnings":[{"period":"1week","weight":0.0159},{"period":"1month","weight":0.0922},{"period":"3month","weight":-0.0857},{"period":"6month","weight":-0.0935},{"period":"1year","weight":-0.3074},{"period":"ytd","weight":-0.292}],"companyName":"海南海药股份有限公司","boardCode":"AI0027","perCapita":"24921股","boardName":"医药制造业","registeredCapital":"129736万元","compareEarnings":[{"period":"1week","weight":0.0124},{"period":"1month","weight":-0.0297},{"period":"3month","weight":-0.0837},{"period":"6month","weight":-0.0194},{"period":"1year","weight":-0.0761},{"period":"ytd","weight":-0.0273}],"survey":" 海南海药股份有限公司主营业务是药品及医疗器械研发、生产和销售。公司的主要产品是抗生素系列、胃肠道用药系列、抗肿瘤药系列、与制剂配套的原料药和中间体系列及其他产品。公司产品枫蓼肠胃康颗粒2023年市场占有率56%，国内排名第一，头孢唑肟钠2023年市场占有率10.6%，国内排名第二，头孢西丁钠2023年市场占有率15.9,%，国内排名第二。","serverTime":1724170420935,"listedPrice":5.8,"stockholders":"46784人(较上一季度增加0.23%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海南海药(000566)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海南海药(000566)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海南海药,000566,海南海药股票,海南海药股票老虎,海南海药股票老虎国际,海南海药行情,海南海药股票行情,海南海药股价,海南海药股市,海南海药股票价格,海南海药股票交易,海南海药股票购买,海南海药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海南海药(000566)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海南海药(000566)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}